SynthesisAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients with Heterozygous Familial Hypercholesterolemia: A Meta-analysis.

Mahsa Movahedan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.